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Introduction
Dobutamine stress studies after acute ST or Non-ST
elevation myocardial infarction (STEMI, NSTEMI, AMI)
have prognostic implications for future cardiovascular
events and therefore have an impact on the indicated
therapy by identifying high-risk patients. Dobutamine
side effects early after AMI have been extensively
reported. Namely malignant arrhythmias are feared,
since mostly the initiated beta blocker therapy was inter-
rupted for stress studies to achieve the required sub-
maximal heart rate increase.
Purpose
To date, no data exists on the feasibility of dobutamine
stress MRI (DSMR) in patients (pts.) very early after
AMI with continued beta-blocker therapy. Therefore we
sought to investigate the side effects and safety of
DSMRI early after AMI.
Material and methods
144 pts. with a first uncomplicated AMI underwent
DSMR (max. 40mg/kg bw/min plus atropine if needed)
for detection of ischemia under continuous high dose
beta blocker therapy. Studies were terminated after
reaching sub-maximal heart rate (calculated by 200-age-
10% beats-per-minute(bpm)) or typical chest-pain/dys-
pnoea/malignant arrhythmia. Stress-induced wall motion
deterioration was considered as positive DSMR. DSMR
was conducted in a 1.5T whole body MRI (Philips), vital
parameters like heart rate, blood pressure and -satura-
tion were monitored continuously.
Results
W es t u d i e d6 3S T E M Ia n d8 1N S T E M I( m e a na g e6 6
±12, 15% female). 36pts. had a one-, 26pts. a two- and
79 pts. three-vessel disease with 127 stents implanted.
Maximal Troponin T was 2.96±3.68ng/dl. NT-pro BNP
was 2422±3838ng/l. Clinical reasons for DSMR were
assessment of a) ischemia (126 pts.) and b) viability
(18 pts). DSMR was conducted in 94% successfully. Sub-
maximal heart rate was reached in approximately 85% of
pts (from 64±12to115±21/bpm). 81% of pts. received the
maximal 40-dobutamine dose pre-discharge (4.9±2.1days
after AMI). 40% obtained additional atropine (max.
2mg) regardless whether STEMI or NSTEMI had
occurred. During DSMR 18 pts. reported chest pain,
8 pts had dyspnoea. In 16 pts. DSMR detected new wall
motion abnormalities suspicious of myocardial ischemia.
Conclusions
After AMI conduction of DSMR was safe and well toler-
ated by all pts. Potentially due to the continued beta-
blocker therapy, no malignant arrhythmias occurred
although 85% of pts. reached the required sub-maximal
heart rate. Since stress studies after AMI have prognos-
tic implications for future cardiovascular events and are
therefore clinically necessary, high dose DSMR can be
conducted safely under beta-blocker therapy.
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